Effectiveness of the four-component protein-based meningococcal vaccine against Neisseria gonorrhoeae infections: Mounting evidence and public health implications for Canada
If results of observational studies are confirmed by randomized trials with an acceptable cost-effectiveness profile in the Canadian context, a targeted immunization program using 4CMenB could be implemented.
Authors
- Michaël Desjardins (ORCID: https://orcid.org/0000-0003-4028-8507)
- Yen‐Giang Bui
- Philippe De Wals (ORCID: https://orcid.org/0000-0002-9239-3096)
Institutions
- Institut National de Santé Publique du Québec (CA)
- Centre Hospitalier de l’Université de Montréal (CA)
- Université Laval (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- Canada Communicable Disease Report
- Published
- 2025-08-28
- DOI
- https://doi.org/10.14745/ccdr.v51i08a04
- Citations
- 2
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 2.37